Earning Preview: Ametek Inc revenue is expected to increase by 7.00%, and institutional views are predominantly bullish

Earnings Agent
Jan 27

Abstract

Ametek Inc will report its quarterly results on February 03, 2026 Pre-Market; consensus points to continued revenue and EPS growth with stable margins, while institutional commentary trends positive on execution and portfolio quality.

Market Forecast

For the current quarter, forecasts indicate total revenue of USD 1.95 billion with year-over-year growth of 7.00%, EBIT of USD 515.49 million with year-over-year growth of 10.46%, and adjusted EPS of USD 1.95 with year-over-year growth of 4.07%. Margin expectations imply continued disciplined pricing and cost control supporting gross profit margin and net profit margin stability near recent levels. The main business highlights center on Electronic Instruments and Electromechanical, where demand appears resilient across aerospace, automation, and utilities. The most promising segment is Electronic Instruments, with last quarter revenue of USD 1.25 billion and a revenue share of 65.85%; momentum is supported by commercial aerospace and test-and-measure applications.

Last Quarter Review

In the previous quarter, Ametek Inc reported revenue of USD 1.89 billion, gross profit margin of 36.66%, GAAP net profit attributable to the parent company of USD 371.00 million, net profit margin of 19.62%, and adjusted EPS of USD 1.89, with year-over-year growth of 13.86%. A notable financial highlight was the quarter-on-quarter growth in GAAP net profit of 3.64%, reflecting operational leverage and a balanced mix of volume and pricing. Main business highlights included Electronic Instruments revenue of USD 1.25 billion and Electromechanical revenue of USD 646.31 million; the mix underscores the company’s emphasis on high-value instrumentation, with Electronic Instruments representing 65.85% of total revenue.

Current Quarter Outlook

Electronic Instruments Segment

Electronic Instruments remains the largest revenue contributor and is central to Ametek Inc’s quarterly narrative. With last quarter revenue at USD 1.25 billion, the segment benefits from steady demand in commercial aerospace avionics, process instrumentation, and advanced test and measurement solutions that typically demonstrate stable procurement cycles. Pricing discipline and a high mix of differentiated products should help sustain gross profit margin around recent levels, even as input costs fluctuate. The quarter’s stock performance sensitivity will be tied to whether Electronic Instruments delivers mid-single to high-single-digit revenue growth, consistent backlog conversion, and aligns with EPS guidance, which is forecast at USD 1.95.

Electromechanical Segment

Electromechanical, which delivered USD 646.31 million last quarter, is expected to provide incremental support to margins and volume through motors, motion control, and precision components. Analyst commentary highlights improving medical and automation end markets that support electromechanical demand, complementing steady utility trends. The segment’s contribution to EBIT expansion is likely constructive if backlog execution and supply-chain stability sustain throughput. Any upside surprise in Electromechanical would likely manifest through better-than-expected operating efficiency, contributing to the forecast EBIT of USD 515.49 million and reinforcing the quarter’s EPS trajectory.

Stock Price Drivers This Quarter

The stock’s near-term reaction will hinge on revenue growth alignment with the USD 1.95 billion forecast, EPS meeting or beating USD 1.95, and margin stability against recent benchmarks. Investors will watch whether gross profit margin remains close to 36.66% and net profit margin near 19.62% while year-over-year improvements materialize in EBIT and EPS, as currently projected. Execution on order conversion within Electronic Instruments, plus demand resilience in electromechanical across aerospace and automation, will factor into sentiment. A clean beat on revenue and EPS, combined with confirmation of backlog health, would support the prevailing bullish institutional stance.

Analyst Opinions

The ratio of bullish versus bearish or neutral opinions over the past six months is skewed toward bullish, with the majority of recent institutional commentary indicating positive expectations. TD Cowen upgraded Ametek Inc to Buy with a USD 230.00 price target, citing support from steady utility markets, fast-growing commercial aerospace, and improving medical and automation exposure; the brokerage also highlighted steady gains expected in the electromechanical unit through 2026 and a constructive view on recent portfolio moves. Mizuho Securities maintained a Buy rating with a USD 225.00 price target, reflecting confidence in execution and margin discipline aligned with the company’s forecast profile. While Barclays maintained an Equal Weight/Hold stance, broader coverage data show a larger proportion of Buy recommendations and a median price target around USD 230.00, signaling constructive institutional sentiment.

Collectively, the majority view anticipates Ametek Inc to post another quarter of growth in revenue and EPS, supported by operational consistency and segment balance. The Electronic Instruments segment’s performance is expected to anchor the result, with Electromechanical contributing to EBIT expansion if supply-chain conditions remain stable. The market is keyed to delivery versus the USD 1.95 billion revenue and USD 1.95 EPS forecasts; a modest beat, coupled with confirmation of demand strength in commercial aerospace and automation, would reinforce the prevailing bullish narrative.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10